Stay updated on Belzutifan + Cabozantinib in ccRCC Clinical Trial
Sign up to get notified when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.

Latest updates to the Belzutifan + Cabozantinib in ccRCC Clinical Trial page
- Check7 days agoChange DetectedThe page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference1%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.9%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check42 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has been updated to reflect a new version of the study protocol for the combination of belzutifan and cabozantinib in treating advanced clear cell renal cell carcinoma (ccRCC), with significant details about the study's design and criteria removed.SummaryDifference18%
Stay in the know with updates to Belzutifan + Cabozantinib in ccRCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belzutifan + Cabozantinib in ccRCC Clinical Trial page.